FULGENT GENETICS, INC. Investing Cash Flow
FULGENT GENETICS, INC. (FLGT) reported Investing Cash Flow of $61.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $50.80M, a 4.87% decline year-over-year.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $10.94M, a 60.55% decline year-over-year.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $11.15M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $19.08M, a 112.40% increase year-over-year.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $111.37M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$58.35M, a 250.01% decline from fiscal 2023.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was $38.90M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$261.31M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $61.74M 10-Q · filed 2026-07-30 | $72.89M derived: sum of 3 quarters · filed 2026-07-30 | $91.98M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $10.94M 10-Q · filed 2026-05-01 | $22.09M derived: sum of 2 quarters · filed 2026-05-01 | $41.18M derived: sum of 3 quarters · filed 2026-05-01 | $94.58M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $11.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $30.24M derived: sum of 2 quarters · filed 2026-02-27 | $83.64M derived: sum of 3 quarters · filed 2026-07-30 | $111.37M 10-K · filed 2026-02-27 |
| 2025-09-30 | $19.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $72.49M derived: sum of 2 quarters · filed 2026-07-30 | $100.22M 10-Q · filed 2025-11-07 | $72.76M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $53.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $81.13M 10-Q · filed 2026-07-30 | $53.68M derived: sum of 3 quarters · filed 2026-07-30 | $62.66M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $27.73M 10-Q · filed 2026-05-01 | $274.00K derived: sum of 2 quarters · filed 2026-05-01 | $9.26M derived: sum of 3 quarters · filed 2026-05-01 | $16.56M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$27.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$18.47M derived: sum of 2 quarters · filed 2026-02-27 | -$11.17M derived: sum of 3 quarters · filed 2026-02-27 | -$58.35M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $16.29M derived: sum of 2 quarters · filed 2025-11-07 | -$30.90M 10-Q · filed 2025-11-07 | -$6.63M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$39.88M 10-Q · filed 2025-08-01 | -$15.61M derived: sum of 3 quarters · filed 2026-02-27 | $4.47M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$47.19M 10-Q · filed 2025-05-02 | -$22.92M derived: sum of 2 quarters · filed 2026-02-27 | -$2.84M derived: sum of 3 quarters · filed 2026-02-27 | -$3.93M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $24.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $44.35M derived: sum of 2 quarters · filed 2026-02-27 | $43.25M derived: sum of 3 quarters · filed 2026-02-27 | $38.90M 10-K · filed 2026-02-27 |
| 2023-09-30 | $20.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $18.98M derived: sum of 2 quarters · filed 2024-11-08 | $14.63M 10-Q · filed 2024-11-08 | -$77.97M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$5.45M 10-Q · filed 2024-08-02 | -$98.05M derived: sum of 3 quarters · filed 2025-02-28 | -$53.76M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$4.35M 10-Q · filed 2024-05-03 | -$96.95M derived: sum of 2 quarters · filed 2025-02-28 | -$52.66M derived: sum of 3 quarters · filed 2025-02-28 | -$266.36M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$92.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$48.31M derived: sum of 2 quarters · filed 2025-02-28 | -$262.00M derived: sum of 3 quarters · filed 2025-02-28 | -$261.31M 10-K · filed 2025-02-28 |
| 2022-09-30 | $44.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$169.40M derived: sum of 2 quarters · filed 2023-11-03 | -$168.72M 10-Q · filed 2023-11-03 | -$308.97M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$213.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$213.00M 10-Q · filed 2023-08-04 | -$353.26M derived: sum of 3 quarters · filed 2024-02-28 | -$388.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $688.00K 10-Q · filed 2023-05-05 | -$139.57M derived: sum of 2 quarters · filed 2024-02-28 | -$174.36M derived: sum of 3 quarters · filed 2024-02-28 | -$329.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$140.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$175.05M derived: sum of 2 quarters · filed 2024-02-28 | -$330.06M derived: sum of 3 quarters · filed 2024-02-28 | -$546.55M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$34.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$189.80M derived: sum of 2 quarters · filed 2022-11-07 | -$406.29M 10-Q · filed 2022-11-07 | -$725.06M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$155.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$371.50M 10-Q · filed 2022-08-04 | -$690.26M derived: sum of 3 quarters · filed 2023-02-28 | -$691.67M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$216.49M 10-Q · filed 2022-05-05 | -$535.26M derived: sum of 2 quarters · filed 2023-02-28 | -$536.66M derived: sum of 3 quarters · filed 2023-02-28 | -$539.07M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$318.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$320.17M derived: sum of 2 quarters · filed 2023-02-28 | -$322.58M derived: sum of 3 quarters · filed 2023-02-28 | -$326.44M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$3.81M derived: sum of 2 quarters · filed 2021-11-09 | -$7.67M 10-Q · filed 2021-11-09 | -$43.75M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$6.27M 10-Q · filed 2021-08-10 | -$42.35M derived: sum of 3 quarters · filed 2022-02-28 | -$36.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$3.86M 10-Q · filed 2021-05-07 | -$39.94M derived: sum of 2 quarters · filed 2022-02-28 | -$33.60M derived: sum of 3 quarters · filed 2022-02-28 | -$30.39M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$36.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$29.73M derived: sum of 2 quarters · filed 2022-02-28 | -$26.52M derived: sum of 3 quarters · filed 2022-02-28 | -$29.05M 10-K · filed 2022-02-28 |
| 2019-09-30 | $6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.55M derived: sum of 2 quarters · filed 2020-11-09 | $7.03M 10-Q · filed 2020-11-09 | $4.50M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $689.00K 10-Q · filed 2020-08-05 | -$1.85M derived: sum of 3 quarters · filed 2020-08-05 | $3.12M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$2.52M 10-Q · filed 2020-05-06 | -$5.06M derived: sum of 2 quarters · filed 2020-05-06 | -$96.00K derived: sum of 3 quarters · filed 2020-05-06 | -$1.62M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $2.43M derived: sum of 2 quarters · filed 2020-03-13 | $899.00K derived: sum of 3 quarters · filed 2020-03-13 | $950.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.44M derived: sum of 2 quarters · filed 2019-11-08 | $3.49M 10-Q · filed 2019-11-08 | $1.72M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$1.48M 10-Q · filed 2019-08-12 | -$3.24M derived: sum of 3 quarters · filed 2019-08-12 | -$5.81M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $51.00K 10-Q · filed 2019-05-10 | -$1.71M derived: sum of 2 quarters · filed 2019-05-10 | -$4.28M derived: sum of 3 quarters · filed 2019-05-10 | -$128.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$4.33M derived: sum of 2 quarters · filed 2019-03-22 | -$179.00K derived: sum of 3 quarters · filed 2019-03-22 | -$2.05M 10-K · filed 2019-03-22 |
| 2017-09-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.58M derived: sum of 2 quarters · filed 2018-11-09 | -$286.00K 10-Q · filed 2018-11-09 | -$39.70M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $2.28M 10-Q · filed 2018-08-13 | -$37.13M derived: sum of 3 quarters · filed 2018-08-13 | -$39.95M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$1.87M 10-Q · filed 2018-05-14 | -$41.29M derived: sum of 2 quarters · filed 2018-05-14 | -$44.10M derived: sum of 3 quarters · filed 2018-05-14 | -$44.49M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | -$39.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$42.23M derived: sum of 2 quarters · filed 2018-03-20 | -$42.62M derived: sum of 3 quarters · filed 2018-03-20 | -$42.80M 10-K · filed 2018-03-20 |
| 2016-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$3.20M derived: sum of 2 quarters · filed 2017-11-13 | -$3.38M 10-Q · filed 2017-11-13 | -$3.65M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$563.00K 10-Q · filed 2017-08-14 | -$838.00K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$177.00K 10-Q · filed 2017-05-09 | -$452.00K derived: sum of 2 quarters · filed 2017-05-09 | ||
| 2015-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$2.21M 10-K · filed 2017-03-17 | ||
| 2015-09-30 | -$1.93M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | -$780.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |